Contineum Therapeutics (CTNM) Times Interest Earned (2023)

Contineum Therapeutics' Times Interest Earned history runs 4 years deep, the most recent figure standing at -$0.42 for Q2 2026.

• In Q2 2026, Times Interest Earned rose 83.91% year-over-year to -$0.42; the TTM figure through Jun 2026 stood at -$1.59 (up 83.39% YoY), while the FY2025 annual figure was -$1.42, up 0.96% from the prior year.
• Times Interest Earned for Q2 2026 stood at -$0.42, up from -$0.7 in the prior quarter.
• The five-year high for Times Interest Earned was $335.66 in Q2 2023, with the low at -$135.29 in Q4 2024.
• The 4-year median for Times Interest Earned is -$0.75 (2025), against an average of $25.84.
• The sharpest annual moves came in 2024 and 2025: Times Interest Earned surged 99.34% in 2024, then slumped 578.07% in 2025.
• Contineum Therapeutics' Times Interest Earned stood at $166.83 in 2023, then tumbled by 181.1% to -$135.29 in 2024, then soared by 85.17% to -$20.06 in 2025, then soared by 97.92% to -$0.42 in 2026.
• Business Quant data shows CTNM's Times Interest Earned at -$0.42 in Q2 2026, -$0.7 in Q1 2026, and -$20.06 in Q4 2025.